SEC Form 4 · accession 0001144204-18-000667
BIOLIFE SOLUTIONS INC · BLFS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jan 1, 2018
Accepted (ET)
Jan 3, 2018 · 9:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000834365
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 1, 2018 | A | 10,000 | — | A | 2,823,843 | I | By Taurus |
| Common StockF2 | Jan 3, 2018 | A | 834 | — | A | 2,824,677 | I | By Taurus |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The restricted stock was granted to Taurus4757 GmbH ("Taurus"), a wholly owned entity of the reporting person, pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments.
- F2The shares of common stock were issued to Taurus pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of the reporting person receiving $5,000 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter.